CLINICAL_TRIALS
trial_result
· 2023-03-08
Clinical Trial Update: Solriamfetol in Binge Eating Disorder [Phase 4]
Summary
Clinical trial update for solriamfetol in binge eating disorder in Phase 4 is ongoing with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lindner Center of HOPE | Conditions: Binge Eating Disorder | Phase 4 | Status: UNKNOWN